en

PRODUCT DETAIL

Azacitidine betapharm 25 mg/ml prášok na injekčnú suspenziu

Code 3908D
MA number EU/1/19/1416/001
Product Form: plv inu 1x100 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01B ANTIMETABOLITES
L01BC Pyrimidine analogues
L01BC07 Azacitidine
Shelf life: 36
Container: glass vial
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 24.03.2020
Validity: 24.03.2025
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 03.04.2020
eu-flag.png sk-flag.png